Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of mifepristone + misoprostol for medical termination of early intrauterine pregnancy
jRCT2080224923Phase 3Completed
- Sponsor
- Linepharma International
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mifepristone and misoprostol in pregnancy, sponsored by Linepharma International. Started Oct 2019; status: completed.
02
Drugs
mifepristonemisoprostol
03
Conditions
pregnancy
Beyond the preview
Go deeper on jRCT2080224923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224923.